Vimarsana
Biggest News Aggregation in the World

Page 24 - Presection News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Presection. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Presection Today - Breaking & Trending Today

In Metastatic Breast Cancer, Primary Resections on the Decline - Vimarsana News

In Metastatic Breast Cancer, Primary Resections on the Decline

Surgical resection rates of the primary tumor in metastatic breast cancer has declined in recent years, possibly reflecting changes in practice after trails showed no survival benefit.

Surveillance After ESD for Dysplasia and Early-Stage GI Cancer - Vimarsana News

Surveillance After ESD for Dysplasia and Early-Stage GI Cancer

Proposed surveillance intervals and strategies are necessary following endoscopic submucosal dissection of dysplasia and early gastrointestinal cancer considered pathologically curative.

FDA Expands Pembrolizumab Approval for Advanced Melanoma - Vimarsana News

FDA Expands Pembrolizumab Approval for Advanced Melanoma

The expanded approval is for the adjuvant treatment of advanced melanoma after complete resection in patients aged 12 years and older.

NICE Recommends First Targeted Adjuvant Treatment for Lung Cancer - Vimarsana News

NICE Recommends First Targeted Adjuvant Treatment for Lung Cancer

Osimertinib will be available within the Cancer Drugs Fund for patients with EGFR exon 19 deletions or exon 21 substitution mutations.

Esophageal Cancer Requires Long-term Postop Surveillance - Vimarsana News

Esophageal Cancer Requires Long-term Postop Surveillance

Endoscopic resection of T1 esophageal adenocarcinoma is associated with excellent overall survival, yet long-term surveillance is still required for possible recurrence.